JP2010512393A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010512393A5 JP2010512393A5 JP2009541336A JP2009541336A JP2010512393A5 JP 2010512393 A5 JP2010512393 A5 JP 2010512393A5 JP 2009541336 A JP2009541336 A JP 2009541336A JP 2009541336 A JP2009541336 A JP 2009541336A JP 2010512393 A5 JP2010512393 A5 JP 2010512393A5
- Authority
- JP
- Japan
- Prior art keywords
- solution
- free
- substantially cell
- cells
- assembling peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86943706P | 2006-12-11 | 2006-12-11 | |
| US60/869,437 | 2006-12-11 | ||
| PCT/US2007/025271 WO2008073395A2 (en) | 2006-12-11 | 2007-12-11 | Compositions and methods for cardiac tissue protection and regeneration |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013097308A Division JP5903068B2 (ja) | 2006-12-11 | 2013-05-07 | 心組織の保護および再生のための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010512393A JP2010512393A (ja) | 2010-04-22 |
| JP2010512393A5 true JP2010512393A5 (https=) | 2012-01-12 |
| JP5558104B2 JP5558104B2 (ja) | 2014-07-23 |
Family
ID=39183217
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009541336A Expired - Fee Related JP5558104B2 (ja) | 2006-12-11 | 2007-12-11 | 心組織の保護および再生のための組成物および方法 |
| JP2013097308A Expired - Fee Related JP5903068B2 (ja) | 2006-12-11 | 2013-05-07 | 心組織の保護および再生のための組成物および方法 |
| JP2015228381A Withdrawn JP2016033147A (ja) | 2006-12-11 | 2015-11-24 | 心組織の保護および再生のための組成物および方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013097308A Expired - Fee Related JP5903068B2 (ja) | 2006-12-11 | 2013-05-07 | 心組織の保護および再生のための組成物および方法 |
| JP2015228381A Withdrawn JP2016033147A (ja) | 2006-12-11 | 2015-11-24 | 心組織の保護および再生のための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9012404B2 (https=) |
| EP (1) | EP2089047B1 (https=) |
| JP (3) | JP5558104B2 (https=) |
| DK (1) | DK2089047T3 (https=) |
| ES (1) | ES2400294T3 (https=) |
| WO (2) | WO2008073392A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3031466B1 (en) * | 2004-07-06 | 2018-11-28 | 3D Matrix, Inc. | Purified amphiphilic peptide compositions and uses thereof |
| EP2229960B1 (en) * | 2007-12-05 | 2015-04-08 | 3-D Matrix, Ltd. | Wound healing/skin reconstruction material |
| KR101670099B1 (ko) | 2008-10-06 | 2016-10-27 | 가부시끼가이샤 쓰리디 매트릭스 | 조직 폐색제 |
| AU2010206543A1 (en) * | 2009-01-26 | 2011-07-07 | Intermune, Inc. | Methods for treating acute myocardial infarctions and associated disorders |
| US20110117195A1 (en) * | 2009-11-18 | 2011-05-19 | National Cheng Kung University | Method for improving myocardial infarction by intramyocardial or transendocardial injection of peptide nanofibers |
| US20140329914A1 (en) * | 2011-09-02 | 2014-11-06 | 3-D Matrix Ltd. | Amphiphilic Peptides for Thoracic Air Leakage Occlusion |
| US11260072B2 (en) | 2011-09-07 | 2022-03-01 | 3-D Matrix, Ltd. | MicroRNA-based methods and assays for osteocarcinoma |
| US10905708B2 (en) | 2011-09-07 | 2021-02-02 | 3-D Matrix, Ltd. | MicroRNA-based methods and assays for osteocarcinoma |
| EP2869903B1 (en) | 2012-07-06 | 2018-11-28 | 3-D Matrix Ltd. | Fill-finish process for peptide solutions |
| JP2015021582A (ja) | 2013-07-22 | 2015-02-02 | 株式会社ジェイテクト | 円錐ころ軸受と円錐ころ軸受を用いた動力伝達装置 |
| ES2712608T3 (es) | 2014-03-10 | 2019-05-14 | 3 D Matrix Ltd | Péptidos autoensamblantes para el tratamiento de las bullas pulmonares |
| WO2015136370A2 (en) | 2014-03-10 | 2015-09-17 | 3-D Matrix, Ltd. | Sterilization and filtration of peptide compositions |
| AU2015229549B2 (en) | 2014-03-10 | 2019-05-23 | 3-D Matrix, Ltd. | Self-assembling peptide compositions |
| DE102015000363A1 (de) | 2015-01-20 | 2016-07-21 | Emc Microcollections Gmbh | Neue modular funktionalisierbare Peptid-Hydrogele |
| JP6134081B1 (ja) | 2015-12-10 | 2017-05-24 | 株式会社メニコン | ペプチド組成物 |
| US10814038B2 (en) | 2016-01-06 | 2020-10-27 | 3-D Matrix, Ltd. | Combination compositions |
| US11174288B2 (en) | 2016-12-06 | 2021-11-16 | Northeastern University | Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria |
| CN117085140A (zh) | 2017-12-15 | 2023-11-21 | 立美基股份有限公司 | 表面活性剂肽纳米结构及在药物递送中的用途 |
| EP3818071A2 (en) * | 2018-07-03 | 2021-05-12 | 3-D Matrix, Ltd. | Ionic self-assembling peptides |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5670483A (en) | 1992-12-28 | 1997-09-23 | Massachusetts Insititute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| MXPA02012890A (es) * | 2000-07-06 | 2003-10-24 | Wyeth Corp | Uso de compuestos de indol sustituidos para incrementar la actividad de oxido nitrico sintasa. |
| US7449180B2 (en) * | 2001-02-06 | 2008-11-11 | John Kisiday | Macroscopic scaffold containing amphiphilic peptides encapsulating cells |
| WO2003096972A2 (en) | 2002-05-13 | 2003-11-27 | Massachusetts Institute Of Technology | Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof |
| HRP20050655A2 (en) * | 2003-01-16 | 2006-05-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| US7713923B2 (en) * | 2003-06-25 | 2010-05-11 | Massachusetts Institute Of Technology | Self-assembling peptides incorporating modifications and methods of use thereof |
| WO2005014615A2 (en) * | 2003-06-25 | 2005-02-17 | Massachusetts Institute Of Technology | Self-assembling peptides incorporating modifications and methods of use thereof |
| JP4813771B2 (ja) * | 2004-04-14 | 2011-11-09 | 丸善製薬株式会社 | 血管内皮型一酸化窒素合成酵素活性促進剤 |
| EP3031466B1 (en) | 2004-07-06 | 2018-11-28 | 3D Matrix, Inc. | Purified amphiphilic peptide compositions and uses thereof |
| JP4949661B2 (ja) * | 2004-09-21 | 2012-06-13 | 第一三共株式会社 | ＨＭＧ−ＣｏＡリダクターゼ阻害剤とグルタチオンを含有する医薬組成物 |
| EP1833504A4 (en) * | 2005-01-04 | 2009-08-12 | Brigham & Womens Hospital | PERMANENT DELIVERY OF SELF-ARRANGING PEPTIDE NANOFIBER USING THE PDGF |
| EP1879606B1 (en) | 2005-04-25 | 2013-06-12 | Massachusetts Institute of Technology | Self-assembling peptides for promoting hemostasis |
-
2007
- 2007-12-11 US US12/518,624 patent/US9012404B2/en active Active
- 2007-12-11 ES ES07867700T patent/ES2400294T3/es active Active
- 2007-12-11 WO PCT/US2007/025267 patent/WO2008073392A2/en not_active Ceased
- 2007-12-11 JP JP2009541336A patent/JP5558104B2/ja not_active Expired - Fee Related
- 2007-12-11 DK DK07867700.2T patent/DK2089047T3/da active
- 2007-12-11 EP EP07867700A patent/EP2089047B1/en not_active Not-in-force
- 2007-12-11 WO PCT/US2007/025271 patent/WO2008073395A2/en not_active Ceased
-
2013
- 2013-05-07 JP JP2013097308A patent/JP5903068B2/ja not_active Expired - Fee Related
-
2015
- 2015-03-27 US US14/671,902 patent/US20150258166A1/en not_active Abandoned
- 2015-11-24 JP JP2015228381A patent/JP2016033147A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010512393A5 (https=) | ||
| Haylor et al. | Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I | |
| JP7175506B2 (ja) | 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ | |
| WO2008073395A3 (en) | Compositions and methods for cardiac tissue protection and regeneration | |
| US11414474B2 (en) | Long-acting adrenomedullin derivatives | |
| AU2005251386B2 (en) | Compositions and methods for treatment of cardiovascular disease | |
| JP2014506787A5 (https=) | ||
| CA2740989A1 (en) | Compositions and methods for treatment of kidney fibrosis comprising vasoactive intestinal peptide (vip) or functional vip fragments | |
| US20020032167A1 (en) | High efficiency cardiac gene transfer | |
| WO2017152039A1 (en) | Protection and delivery of multiple therapeutic proteins | |
| KR20210093958A (ko) | 미토콘드리아 질환을 표적으로 하는 유사체 | |
| EP1031352B1 (en) | Use of desmopressin in the preparation of a metastatic dissemination inhibitor medicament during cancer surgery | |
| JPWO2021148411A5 (https=) | ||
| CN108815171A (zh) | 25-羟基胆固醇在制备治疗或预防心肌梗死的药物中的应用 | |
| US20250276116A1 (en) | Methods of mitigating myocardial damage due to extracorporeal membrane oxygenation | |
| WO2012138043A2 (en) | Therapeutic composition containing endothelin as an active component | |
| Hatori et al. | Coronary venous retroinfusion of felodipine reduces myocardial necrosis after coronary occlusion and reperfusion | |
| HK40050536A (en) | Angiotensin ii alone or in combination for the treatment of hypotension | |
| CN107050435B (zh) | 一种钠尿肽极化液及其制备方法和应用 | |
| CN103006632B (zh) | 化合物Clik148在制备治疗脑血管疾病的药物中的应用 | |
| WO2025133111A1 (en) | Cgrp receptor agonists in ischemic heart disease | |
| has been proposed that EDs | Letters to the | |
| Hatada et al. | Direct delivery of neuronal nitric oxide synthase into myocardium improves heart failure after acute myocardial infarction in rats | |
| Kamiya et al. | Beta-3 adrenergic receptor agonist prevents diastolic dysfunction in angiotensin2-induced cardiomyopathy mouse model | |
| JP2016141677A (ja) | 心筋梗塞縮小薬 |